Valuation: Cutera

Market Cap 7.12M 6.27M 5.82M 5.35M 10.04M 690M 10.22M 69.6M 27.15M 336M 26.74M 26.17M 1.17B P/E 2022
-10.1x
P/E 2023 -0.43x
Enterprise Value 295M 260M 241M 222M 416M 28.61B 424M 2.89B 1.13B 13.95B 1.11B 1.09B 48.41B EV / Sales 2022
3.89x
EV / Sales 2023 1.69x
Free-Float
-
Yield 2022 *
-
Yield 2023 -
3 years 0
Extreme 0.005
21.41
5 years 0
Extreme 0.005
74.38
10 years 0
Extreme 0.005
74.38
Manager TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 60 2023-05-04
Investor Relations Contact - -
Director TitleAgeSince
Chairman 57 2023-06-30
Director/Board Member 67 2023-04-30
Director/Board Member 49 2023-05-18
Date Insider Type Main position Quantity % Market Cap.
2/13/25 Tax

General Counsel

623 0.0031%
2/7/25 Tax

Chief Executive Officer

4,620 0.0229%
2/1/25 Tax

Chief Financial Officer

22 0.0001%

Financials

2022 2023
Net sales 252M 222M 206M 190M 356M 24.44B 362M 2.47B 962M 11.92B 948M 927M 41.36B 212M 187M 174M 160M 299M 20.57B 305M 2.07B 809M 10.03B 797M 780M 34.8B
Net income -82.34M -72.42M -67.28M -61.88M -116M -7.97B -118M -804M -314M -3.89B -309M -302M -13.49B -163M -143M -133M -122M -229M -15.77B -234M -1.59B -621M -7.69B -611M -598M -26.68B
Net Debt 115M 101M 93.65M 86.13M 162M 11.1B 164M 1.12B 437M 5.41B 430M 421M 18.78B 288M 254M 236M 217M 406M 27.92B 414M 2.82B 1.1B 13.62B 1.08B 1.06B 47.24B
Logo Cutera
Cutera, Inc. is a provider of aesthetic and dermatology solutions for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured Secret systems and consumables. It markets various system platforms, such as AviClear, enlighten, excel V/V+, excel HR, truSculpt, Secret PRO, Secret DUO Secret RF, xeo, and xeo+, each of which enables medical practitioners to perform procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. With its xeo platform, practitioners can purchase customized systems with a variety of the Company’s multi-technology applications. Each of the Company’s products consists of a control console and one or more hand pieces, depending on the model.
Employees
430
Sector
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. CUTR Stock